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ABSTRACT 
 
In humans, more than 200 missense mutations have been identified in the ACTA1 gene. The 
exact molecular mechanisms by which, these particular mutations become toxic and lead to 
muscle weakness and myopathies remain obscure. To address this, here, we performed a 
molecular dynamics simulation, and we used a broad range of biophysical assays to determine 
how the lethal and myopathy-related H40Y amino acid substitution in actin affects the 
structure, stability, and function of this protein. Interestingly, our results showed that H40Y 
severely disrupts the DNase I-binding-loop structure and actin filaments. In addition, we 
observed that normal and mutant actin monomers are likely to form distinctive 
homopolymers, with mutant filaments being very stiff, and not supporting proper myosin 
binding. These phenomena underlie the toxicity of H40Y and may be considered as important 
triggering factors for the contractile dysfunction, muscle weakness and disease phenotype 
seen in patients.  
 
Keywords: Myopathy, actin, contractile dysfunction, small-angle x-ray scattering, in vitro 
motility assay, molecular dynamics 
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1. INTRODUCTION 
 
More than 200 mutations in the ACTA1 gene have been observed and these are usually 
associated with life-threatening diseases termed congenital myopathies. One common 
pathological feature for most of the patients is severe weakness in their limb, masticatory and 
respiratory muscles [1, 2]. Little is known about the underlying biochemical and biophysical 
mechanisms by which defects in skeletal muscle α-actin ultimately lead to muscle weakness 
[1, 2]. Hence, no cure exists; treatment simply focuses on symptomatic management such as 
respiratory intervention, particularly nocturnal ventilation [1, 2].  
 
In skeletal muscle, actin monomers are crucial for force production and contraction as they 
directly interact with tropomyosin and myosin. In the absence of Ca
2+
, tropomyosin sterically 
hinders interactions
 
between actin and myosin molecules. Upon addition of Ca
2+
, tropomyosin 
moves over the surface of actin exposing myosin-binding sites on actin filaments. Myosin can 
then bind to actin monomers and form myosin cross-bridges, allowing the production of force 
and motion [3]. Most ACTA1 mutations are missense mutations leading to the substitution of 
just one residue in the skeletal muscle α-actin protein. Interestingly, we have shown that, in 
the presence of these amino acid substitutions such as the lethal H40Y [4], the myosin binding 
to actin filaments is greatly disrupted limiting the intrinsic force-generating capacity [5]. In 
the present study, by using a unique combination of molecular dynamics simulation, small-
angle x-ray scattering and in vitro motility assay, we aimed to identify the mechanisms by 
which the myosin attachment to actin monomers is partially prevented in the presence of 
H40Y.  
 
H40Y is located in actin sub-domain 2, in the DNase I-binding loop (also called D-loop, 
residues 38–52). The D-loop establishes a lock-and-key interaction with the neighbouring 
actin monomer by interacting with the C terminus of the adjacent subunit in actin filament. 
The interface is large and is stabilized by electrostatic and hydrophobic interactions and also 
by geometric surface complementarity. Hence, we initially hypothesised that the inefficient 
myosin binding would originate from an altered D-loop structure and actin-actin interface. 
This would, upon activation, prevent changes in the twist of the F-actin helix, limiting 
filament extension and reducing the axial range for myosin heads to find target zones along 
the actin filaments. As a consequence, it would provide less binding sites for myosin 
molecules. 
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2. MATERIALS AND METHODS 
 
2.1.Animals 
 
Two- to three-month old male mice expressing the H40Y skeletal muscle α-actin mutant were 
analysed along with wild-type strain-, age- and gender-matched mice. For a complete 
description of the knock-in mice, please see [4, 5]. Mice were killed by cervical dislocation 
under deep isoflurane sedation and skeletal muscles (Tibialis anterior, TA; and extensor 
digitorum longus, EDL) were dissected. All procedures involving
 
animal care, welfare and 
handling were performed according to institutional
 
guidelines and were reviewed and 
approved by the Animal Ethics Committee of Uppsala University. 
 
2.2.Muscle Preparation And Myofibre Permeabilization  
 
TA and EDL muscles were separated into two portions. One portion was frozen in liquid 
nitrogen-chilled propane and stored at -80°C.  The other portion was placed in relaxing 
solution at 4°C. Bundles of approximately 50 myofibres were dissected free and then tied 
with surgical silk to glass capillary tubes at slightly stretched lengths. They were then treated 
with skinning solution (relaxing solution containing glycerol; 50:50 v/v) for 24 hours at 4°C, 
after which they were transferred to -20°C.  In addition, the muscle bundles were treated with 
sucrose, a cryoprotectant, within 1-2 weeks for long-term storage (17). They were detached 
from the capillary tubes and snap frozen in liquid nitrogen-chilled propane and stored at -
80°C.   
 
2.3.X-ray Diffraction Recordings And Analyses  
 
Two to three days prior to X-ray recordings, bundles were de-sucrosed, transferred to a 
relaxing solution and single myofibres were dissected. Arrays of approximately 30 myofibres 
were set up (18-23). For each myofibre, both ends were clamped to half-split gold meshes for 
electron microscopy (width = 3 mm), which had been glued to precision-machined ceramic 
chips (width = 3 mm) designed to fit to a specimen chamber. The arrays were then transferred 
to the skinning solution and stored at -20°C. Approximately 80 arrays were mounted (10 
arrays per mouse - four knock-in and four wild-type mice - corresponding to approximately 
2,400 attached fibres). 
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On the day of X-ray recordings, arrays were placed in a plastic dish containing a pre-
activating solution and washed thoroughly to remove the glycerol. They were then transferred 
to the specimen chamber, capable of manual length adjustment and force measurement (force 
transducer, AE801, Memscap, Bernin, France), filled with a pre-activating solution. Mean 
sarcomere length was measured and set to 2.50 µm or > 3.60 µm. Subsequently, for arrays at 
a sarcomere length equal to 2.50 µm, x-ray diffraction patterns were recorded at 15°C, first in 
the pre-activating solution and then in the activating solution (pCa 4.5) when maximal steady-
state isometric force was reached. It should be mentioned that the activating solution was 
supplied to the chamber by using a remote-controlled pump. For arrays at a sarcomere length 
> 3.60 µm, the protocol was identical except that pre-activating and activating solutions were 
replaced by low-EGTA rigor and calcium-rigor solutions with 2,3-butanedione monoxime (to 
prevent major sarcomere in-homogeneities).    
 
For each array, approximately 20 to 30 diffraction patterns were recorded (depending on 
myofibre length) for each solution at the BL45XU beamline of SPring-8.  The wavelength 
was 0.1 nm, and the specimen-to-detector distance was 2.00 m or 3.47 m (to maximize the 
spatial resolution to determine filament compliance).  As a detector, a cooled CCD camera 
(C4880, Hamamatsu Photonics; 1000 × 1018 pixels) was used in combination with an image 
intensifier (VP5445, Hamamatsu Photonics). To minimize radiation damage, the exposure 
time was kept low (1-2 s) and the specimen chamber was moved by 100 µm after each 
exposure. Moreover, we placed an aluminum plate (thickness, 0.35–0.5 mm) upstream of the 
specimen chamber. Following the x-ray recordings, background scattering was subtracted, 
and reflection intensities were determined as described elsewhere [6-10].   
 
Relaxing and activating solutions contained 4 mM Mg-ATP, 1 mM free Mg
2+
, 20 mM 
imidazole, 7 mM EGTA, 14.5 mM creatine phosphate, 324 U/mL creatine phosphokinase, 
1000 U/mL catalase, and KCl to adjust
 
the ionic strength to 180 mM and pH to 7.0. 
Dithiothreitol (DTT) was also added (10 mM). The pre-activating solution was identical to the 
relaxing
 
solution, except that the EGTA concentration was reduced to 0.5 mM. The
 
concentrations of free Ca
2+
 were 10
-9.0
 M (relaxing and pre-activating solutions, pCa 9.0) and 
10
-4.5
 M (activating solution, pCa 4.5).  
 
2.4.In vitro motility assay 
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Skeletal muscle α-actin was purified from thin filaments isolated from frozen wild-type and 
knock-in mouse leg muscles by the method based on that described in Song and co-workers 
and labelled with TRITC phalloidin [11]. The movement of individual actin filaments (more 
than 100 per condition) over a bed of immobilized rabbit fast skeletal muscle heavy 
meromyosin (100 μg/mL) was then evaluated in a motility chamber as previously described 
[12]. Filament movement was recorded and manually tracked yielding speed data [13, 14]. 
 
2.5.Molecular dynamics simulation 
 
One actin filament containing the H40Y mutants composed of subunits with bound Mg
2+
-
ADP was constructed. This was based on vertebrate (rabbit) skeletal muscle actin Protein 
Data Bank entry 2ZWH, with a high-affinity Mg
2+
 cation placed at the nucleotide-binding site 
and the first solvation shell of explicit waters included. The filament contained 13-monomer 
subunits as described in [15-17]. The filament was solvated in explicit TIP3P water 
molecules, with K
+
 and Cl
-
 ions included at a final concentration of 0.18 M using the solvate 
and autoionize tools in VMD [18]. Periodic boundary conditions were introduced such that 
the filament was aligned to repeat along the z direction, interacting with itself at the box 
edges.  
 
The MD simulations were performed using NAMD 2.10 package [19] and the CHARMM 
22/27 force field [20] with CMAP correction [21]. Electrostatic interactions were calculated 
using the particle mesh Ewald sum method with a cutoff of 12 Å. All hydrogen-containing 
covalent bonds were constrained by the SHAKE algorithm, therefore allowing an integration 
time step of 2 fs. Before production runs, an actin filament system was energy minimized, 
heated, and pre-equilibrated for 100 ps in the canonical ensemble while the protein backbone, 
the nucleotide, the active site Mg
2+
, and water oxygen atoms were harmonically restrained 
with spring constant 1 kcal/mol Å
2
. Simulations were then continued in the constant NPT 
ensemble (310K and 1 atm) for an additional 200 ps. Langevin thermostats with a damping 
coefficient of 0.5 ps
-1
 were used to control the system temperature. A Langevin-piston 
barostat with a piston period of 2 ps and a damping time of 2 ps was used to control the 
pressure. Constraints were next released step-wise (with spring constant gradually decrease 
from 1 kcal/mol Å
2 to 0 by steps of 0.1 kcal/mol Å
2
) over a total of 100 ps before starting the 
production runs. A total of 245 ns of data were generated for the H40Y actin filament 
systems. Only data after the system were equilibrated were taken for further analysis. The 
final 190 ns of data were used for analysis unless otherwise specified. All quantities presented 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
 
 7 
in this article are averaged value over all subunits and the simulation windows. All MD data 
are analysed based on the block averages method [22]. All errors in the MD results section 
refer to standard deviation (SD). 
 
2.6.Statistics  
 
The unpaired Student’s t-test was applied, and in cases where the data did not meet the criteria 
of normality (Kolmogorov-Smirnov test, p<0.05), the non-parametric Mann-Whitney rank-
sum test was performed.   
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3. RESULTS AND DISCUSSION 
 
In the present study, we unraveled for the first time the molecular negative events by which 
the toxic H40Y limits the myosin attachment to actin monomers, and reduces the proportion 
of strongly bound myosin cross-bridges. For that, we started by performing a molecular 
dynamics simulation, we then ran a broad range of biophysical assays including small-angle 
x-ray scattering and in vitro motility assay on muscles from one knock-in mouse model 
perfectly recapitulating the human condition [4, 5].  
 
3.1.H40Y stiffens the entire actin filament 
 
The persistence length of actin filament containing H40Y was evaluated using MD 
simulation. It was equal to 12.21±4.64 μm, which is larger than the value previously reported 
for wild-type (WT) filament (9.8 ± 0.14 μm [23]) with p<0.018.  This demonstrates that 
H40Y stiffens actin filaments. To understand the potential underlying mechanisms, we 
measured the crossover length of the filament with thirteen H40Y subunits. The crossover 
length was 357.43±0.60Å, which is smaller than that of WT filament (365±15Å [24]) with 
p<0.00003. In addition, the number of longitudinal contacts between the H40Y D-loop and 
the subunit located above it along the same strand became larger compared to that of WT 
filament. Specifically, all contacts increased between residues 37 and 52 (D-loop) and 
between residues 130 and 150, 161-175, 345-357, and 369-375 of the above subunit. All the 
equilibrated distances between representative structures and coarse-grained (CG) sub-groups 
of the different subunits are summarised in Table 1. All the longitudinal and lateral contact 
distances were found to decrease due to H40Y, except for residue 61–residue 169 (D-loop 
versus SD1) which increased by a small amount and residue 205–residue 286 and residue 
241-residue 322 (SG4 versus SG3) which was very close to the WT value. Most of the 
decreases in equilibrated distances were associated to D-loop structure and explained the 
more frequent contacts between D-loop and the above subunits. These data suggest that in the 
presence of H40Y, the actin subunits become closer, resulting in an unexpectedly large 
amount of longitudinal interactions, stiffening the filament. 
 
We further examined the subunit geometries through coarse-graining residues into relatively 
rigid sub-groups: residues 5–33, 80–147, and 334–349 as SG1; residues 34–39 and 52–59 as 
SG2; residues 148–179 and 273–333 as SG3; residues 180–219 and 252–262 as SG4. We 
denoted the centres of geometry (COGs) for these residues as R1, R2, R3, and R4. 
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Concerning equilibrated structural parameters of filament subunits (inter-subunit bond 
distances, angles, and dihedral angles; Table 2), a few major differences emerged between 
H40Y and WT filament subunits. The equilibrated R1–R2 bond distances differed by a 
considerate amount (21.62 ± 0.35 and 22.99 ± 0.39 for H40Y and WT, respectively). This 
bond distance characterizes the extended distance of SG2 from crystal structure of WT actin. 
Further, the equilibrated R2–R1–R3 angles increased significantly from 102.06 ± 2.06 to 
105.35 ± 1.90 after incorporating the mutation. Also, the equilibrated R2–R1–R3–R4 dihedral 
angles slightly increased from 10.27 ± 3.41 to 11.14 ± 2.61. All these data suggest that H40Y 
alters the subunit structure by shifting the position of SG2 and thus introduces new 
interactions associated to the D-loop with adjacent subunits. In this way, H40Y strengthens 
the actin filament through intra-subunit interactions. To conclude, the stiffness of H40Y actin 
filament originates from a dramatic strengthening of both longitudinal and lateral subunit–D-
loop contacts.     
 
3.2.H40Y partially limits actin filament extensibility upon activation 
 
Simulations tend to suggest that actin filament compliance or extensibility modulates the 
formation of the myosin cross-bridges and force production [25-27]. Indeed, actin filaments 
slightly change their helical symmetry and reach their most untwisted and longest length 
when activated [27, 28]. When extended, F-actin expands the axial range for myosin heads to 
find target zones along the actin filaments, and as a consequence, provides more binding sites 
for myosin molecules when compared with rigid actin filaments [26].   
 
To experimentally evaluate F-actin extensibility in the presence of H40Y, we recorded the 
x-ray diffraction patterns of relaxed and activated single membrane-permeabilized 
myofibres from WT mice and from knock-in rodents expressing H40Y. X-ray experiments 
were possible as the overall sarcomere ultrastructure is preserved in the presence of H40Y 
[5]. We specifically evaluated the actin spacing, which represents the axial distance between 
actin monomers averaged over the whole thin filament in sarcomeres [27]. The 
determination of actin spacing (or actin extensibility) is often achieved using actin layer line 
(ALL) reflections, i.e., 6
th
 ALL (ALL6, d = 5.9 nm) and 7
th
 ALL (ALL7, d = 5.1 nm) [27]. 
In the present study, at an optimal thick and thin filament overlap (mean sarcomere length of 
2.50-2.60 µm), the peaks of ALL6 and ALL7 shifted upon activation. These shifts differed 
between WT and H40Y myofibres but in opposite directions (Figure 2). The ALL6 peak 
shift was smaller for H40Y myofibres when compared with WT cells (~0.08% versus 
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~0.17%) whilst the ALL7 peak shift was greater (~0.13% versus ~0.02%). Hence, the results 
are difficult to interpret. Estimating the actin spacing from ALL6 and ALL7 often leads to 
errors as an imperfect alignment of filament axis may result in the arching of these particular 
reflections. This arching is hardly recognisable by the naked eye as the extension of F-actin 
during contraction is less than 1% (Figure 2). In addition, the peaks of ALL6 and ALL7 are 
broad, leading to additional errors. ALL7 was even weaker than ALL6, increasing the 
probability of errors or misinterpretation. Hence, determining the actin spacing using other 
reflections such as meridional reflections (known to be less influenced by imperfect 
alignments) may overcome such limitations. Following this, we originally recorded and 
analysed the 3
rd
 order meridional reflection of troponin (TN3, d = 12.9 nm) to calculate the 
actin spacing. Its intensity was stably observed in the x-ray diffraction patterns of 
membrane-permeabilized myofibres.   
 
After subtracting the background scattering [6-10], the intensity profile of TN3 was fitted to 
the Gaussian function, and its centre was regarded as the position of the peak. Applying this 
method resulted in a sub-pixel resolution (Figure 3). For fitting purposes, data in the ranges of 
± 4 as well as ± 3 pixels from the observed peak were used. In WT myofibres, at an optimal 
thick and thin filament overlap, the peak shifted by ~0.18% upon maximal activation. This is 
in accordance with our ALL6 results and with data from the literature which observed an 
increase of ~0.20% during maximum tension, corresponding to an elongation of ~3 nm for the 
actin filaments per half-sarcomere [27]. Interestingly, in H40Y myofibres, the widths of the 
observed peaks were visibly wider (standard deviation: 9-10 versus 5-6 pixels). Also the peak 
became asymmetric after maximal activation. For data in the range of ± 4 pixels, the peak 
position changed by only ~0.02% between pCa 9.0 and pCa 4.5 whilst for data in the 
narrower range of ± 3 pixels, it shifted by ~0.17%, i.e., close to the value obtained for WT 
myofibres. These observations suggest that normal and mutant actin molecules in knock-in
 
animals behave differently. The wider TN3 peaks, observed even in myofibres at pCa 9.0 
(rest), suggest that the mutant actin repeat is intrinsically more variable. If normal and mutant 
actin monomers were forming uniform copolymers, then there would not be any asymmetry 
during contraction. Asymmetry has to be caused by normal and mutant actin molecules being 
segregated in distinctive homopolymers. This implies that actin monomers containing H40Y 
are intrinsically polymerized in distinct filaments when compared with normal WT actin 
monomers.  
 
H40Y may primarily stiffen actin monomers and partially prevent filament untwisting upon 
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activation. Considering that H40Y reduces the cross-bridge number and force-generating 
capacity by ~50% [5], and that the amount of mutant proteins in myofibres is ~40% [4], one 
would suggest that stiff actin mutant homopolymers do not support the production of force at 
all.  
 
3.3.H40Y disrupts the contractile function by perturbing interactions with myosin 
and indirectly with tropomyosin 
 
We purified actin from muscles of WT animals and of knock-in mice carrying H40Y. This 
step was possible as H40Y does not affect actin polymerization rate [29], even though the D-
loop is thought to play a role in actin dynamics by slightly modifying its conformation [30]. 
An unloaded in vitro motility assay was then used to measure the speed (Vf) at which myosin 
molecules move WT versus H40Y actin filaments. We observed a Gaussian distribution for 
WT filaments but noticed a biphasic distribution for filaments coming from muscles carrying 
H40Y, with one sub-population behaving as usual (normal Vf, 58% of the filaments had a 
velocity < 3.50 µm.s
-1
) and another being abnormal (increased Vf, 42% of the filaments had a 
velocity > 3.50 µm.s
-1
) (Figure 4). This finding strengthens our suggestion that normal and 
mutant actin monomers are likely to form distinctive homopolymers.  
 
The increased speed of myosin-powered movement for H40Y filaments may arise from a 
change in the properties of the actin filament per se. As previously suggested using a 
computational approach [31], the stiffening of the mutant actin filaments may increase the 
cycling of individual myosin heads by shortening the time spent by individual myosin 
molecules in the strong binding state.  
 
In addition to modifying myosin function, we suspected that H40Y would also alter 
tropomyosin movement. To verify this, we used single membrane-permeabilized myofibres 
from WT rodents and from knock-in mice expressing H40Y. We then monitored the far off-
meridional part of the 2
nd
 ALL (ALL2, d = 19 nm) and measured its intensity change during 
activation under various conditions. ALL2 is one of the most documented reflections in 
vertebrate muscle. During activation, its intensification originates from movement of 
tropomyosin over the thin filament, exposing myosin binding sites on actin filaments [32]. 
Here, at an optimal thick and thin filament overlap (mean sarcomere length of 2.50-2.60 µm), 
we observed a weaker ALL2 intensity change in H40Y myofibres when compared with WT 
cells (Figure 2). In an attempt to identify the origin of such dysfunction (calcium- vs. myosin-
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related), we overstretched myofibres to mean sarcomere length > 3.60 µm to minimize thin-
thick filament overlap [6]. On addition of calcium, the ALL2 intensity change did not differ 
between WT and H40Y myofibres, proving that the myosin-induced movement is specifically 
altered and might be a direct consequence of the disrupted myosin function. 
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4. CONCLUSION 
 
To conclude, our results tend to show that (i) H40Y disrupts the D-loop structure; (ii) normal 
and mutant actin molecules may form separate filaments, rather than uniform copolymers; and 
(iii) abnormal monomers/filaments do not undergo any conformational changes during 
contraction leading to inactive and stiff filaments, preventing proper myosin binding and force 
generation.   
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TABLES 
 
Table 1. Comparison of longitudinal and lateral contacts between H40Y and WT filaments 
 
  Equilibrated distance (A) 
 Residue ID H40Y filament WT filament
a
 
Longitudinal contact    
D loop vs. C-term 41 versus 374 12.64 (1.25) 13.09 (1.5) 
 61 versus 374 23.19 (1.21) 23.29 (1.24) 
 45 versus 370 14.65 (2.23) 14.85 (2.09) 
D loop vs. SD1 45 versus 169 8.62 (1.78) 9.74 (1.74) 
 61 versus 169 13.27 (1.25) 12.78 (1.4) 
D loop vs. SD3 62 versus 288 7.26 (0.53) 7.52 (1.13) 
SD4 vs. SD3 205 versus 286 9.36 (0.89) 9.29 (0.53) 
 241 versus 322 11.08 (1.23) 11.03 (1.76) 
Lateral contact    
H-plug vs. C 265 versus 374 19.47 (1.51) 20.13 (1.15) 
Standard deviations are included between brackets. 
a
Data from [17] 
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Table 2. CG representation of subunit geometries reveals major differences between H40Y 
and WT filaments  
 
 Parameters H40Y equilibrated WT equilibrated
b
 
Bond (A) R1–R2
a
 21.62 (0.35) 22.99 (0.39) 
 R1–R3 24.90 (0.22) 24.85 (0.28) 
 R3–R4 24.93 (0.19) 24.97 (0.28) 
Angle (
o
) R1–R3–R4 74.69 (1.50) 74.42 (1.96) 
 R2–R1–R3 105.35 (1.90) 102.06 (2.06) 
Dihedral (
o
) R2–R1–R3–R4 11.14 (2.61) 10.27 (3.41) 
Standard deviations are included between brackets. 
a
Residue sets: R1: 5–33, 80–147, and 
334–349; R2: 34–39 and 52–59; R3: 148–179 and 273–333; R4: 180–219 and 252–262. bData 
from [17] 
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 FIGURE LEGENDS 
 
Figure 1. Molecular dynamics simulation setup 
(A) Actin subunit structure with rigid portions of SG1, SG2, SG3, and SG4 shown in blue, 
red, cyan, and magenta, respectively, and the COG of each rigid group is represented in a 
sphere of the same colour, labelled as R1, R2, R3, and R4. Upper panel is the subunit crystal 
structure (PDB ID: 2ZWH) and the lower panel is the equilibrated H40Y structure after 
molecular dynamics simulation. Subunit structure D-loop is shown and labelled in yellow. (B) 
An effective infinitely long H40Y actin filament in a periodic boundary condition (PBC) 
water box under physiological conditions.  
 
Figure 2. Actin-layer line (ALL) spacing and intensity profiles 
X-ray diffraction patterns (specimen-to-detector distance: 2.50 m) of membrane-
permeabilised myofibres set at a sarcomere length of 2.50 µm from WT (first row) and from 
H40Y (second row) mice in resting (pCa 9.0, first column) and maximal activating (pCa 4.5, 
second column) conditions. The ALL6 and ALL7 actin spacing increments (in %) as well as 
the ALL2 intensity increment (in fold-change) during activation are presented. Five arrays of 
approximately 30 fibres were tested per mouse (four knock-in and four wild-type mice) for 
these experiments. 
 
Figure 3. TN3 intensity profiles 
X-ray diffraction patterns (specimen-to-detector distance: 3.47 m) of membrane-
permeabilised myofibres set at a sarcomere length of 2.50 µm from WT (first column) and 
from H40Y (second column) mice in resting (pCa 9.0, blue lines on graphs) and maximal 
activating (pCa 4.5, red lines on graphs) conditions. The thinner red and blue curves represent 
the observed data, and the thicker red and blue curves represent the fitted Gaussian function 
with a range of fitting ± 4 pixels or ± 3 pixels. For these experiments, five arrays of 
approximately 30 fibres were mounted per mouse (four knock-in and four wild-type mice). 
 
Figure 4. Actin sliding speed 
This figure displays the means/standard errors as well as distribution of speeds for individual 
filaments coming from WT and H40Y mouse muscles. The star denotes a significant 
difference between WT and H40Y (p<0.05). 
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Fig. 1 
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Fig. 2 
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Fig. 3 
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Fig. 4 
Highlights 
 
 H40Y stiffens the entire actin filament 
 H40Y partially limits actin filament extensibility upon activation 
 H40Y disrupts myosin and tropomyosin function 
